BioForce Nanosciences Holdings's EBIT per Share for the
three
months ended in Mar. 2026 was $-0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.02.
During the past 3 years, the average EBIT per Share Growth Rate was 4.10% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 60.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for BioForce Nanosciences Holdings's EBIT per Share or its related term are showing as below:
BFNH'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -1593.6 Med: 0 Max: 89.4
Current: 4.1
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of BioForce Nanosciences Holdings was 89.40% per year. The lowest was -1593.60% per year. And the median was 0.00% per year.
BFNH's 3-Year EBIT Growth Rate is ranked worse than 55.72% of 1581
companies
in the Consumer Packaged Goods industry
Industry Median: 6.9
vs BFNH: 4.10
BioForce Nanosciences Holdings (OTCPK:BFNH) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
BioForce Nanosciences Holdings EBIT per Share Related Terms
BioForce Nanosciences Holdings EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioForce Nanosciences Holdings EBIT per Share Chart
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioForce Nanosciences Holdings (BFNH) has a EBIT per Share of $-0.02 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on BioForce Nanosciences Holdings and its competitors. According to the industry distribution chart, BioForce Nanosciences Holdings ranks #881 out of 1581 companies in the Consumer Packaged Goods industry, placing it in the top 55.7%.
Is BioForce Nanosciences Holdings' EBIT per Share too high?
BioForce Nanosciences Holdings' current EBIT per Share is $-0.02. Based on the distribution chart, BioForce Nanosciences Holdings ranks #881 out of 1581 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, BioForce Nanosciences Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does BioForce Nanosciences Holdings' EBIT per Share compare to LSF and GWLL?
According to the Consumer Packaged Goods industry distribution chart, BioForce Nanosciences Holdings ranks #881 out of 1581 companies for EBIT per Share. This places BioForce Nanosciences Holdings in the lower half of its industry. The industry median EBIT per Share is 6.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Consumer Packaged Goods company?
The median EBIT per Share among Consumer Packaged Goods companies is 6.90, based on 1,581 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on BioForce Nanosciences Holdings and its competitors. For the Consumer Packaged Goods industry, the median EBIT per Share is 6.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioForce Nanosciences Holdings's current EBIT per Share is $-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioForce Nanosciences Holdings stock overvalued right now?
BioForce Nanosciences Holdings (BFNH) has a current EBIT per Share of $-0.02. The current EBIT per Share is $-0.02. BioForce Nanosciences Holdings' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For BioForce Nanosciences Holdings (BFNH), the current EBIT per Share is $-0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BioForce Nanosciences Holdings Business Description
BioForce Nanosciences Holdings Inc is a provider of natural vitamins, minerals, and other nutritional supplements, powders, and beverages. It markets its products through social media and telemarketing. BioForce currently markets its products through social media and telemarketing. Nutrition retailers, grocery stores, retail pharmacies, and online stores, like Amazon, will be important channels for the Company's Eclipse product-lines.
34GF Score
Get the complete analysis for BFNH
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BFNH has been successfully added to your 
